OSI Systems, NVE, and Clene are the three Nanotechnology stocks to watch today, according to MarketBeat's stock screener tool. Nanotechnology stocks are shares of publicly traded companies that research, develop and commercialize materials, devices or processes at the nanoscale. These firms span industries like medicine, electronics and energy, and their shares often appeal to investors seeking high-growth opportunities—albeit with higher volatility due to the emerging nature of the technology. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.
OSI Systems (OSIS)
OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.
Shares of OSIS stock traded down $5.59 during trading hours on Friday, hitting $230.99. 142,281 shares of the company's stock traded hands, compared to its average volume of 198,327. The stock's 50 day simple moving average is $213.05 and its 200 day simple moving average is $195.44. OSI Systems has a 12 month low of $129.18 and a 12 month high of $241.64. The company has a quick ratio of 1.25, a current ratio of 1.88 and a debt-to-equity ratio of 0.56. The stock has a market cap of $3.88 billion, a PE ratio of 29.68, a price-to-earnings-growth ratio of 1.81 and a beta of 1.28.
Read Our Latest Research Report on OSIS
NVE (NVEC)
NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.
NVE stock traded down $2.53 during midday trading on Friday, reaching $69.40. The stock had a trading volume of 26,214 shares, compared to its average volume of 32,809. The company has a market capitalization of $335.69 million, a P/E ratio of 22.39 and a beta of 1.15. NVE has a 12 month low of $51.50 and a 12 month high of $89.98. The company has a fifty day moving average price of $65.14 and a two-hundred day moving average price of $70.61.
Read Our Latest Research Report on NVEC
Clene (CLNN)
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.
CLNN stock traded up $0.05 during trading on Friday, reaching $4.13. The stock had a trading volume of 62,397 shares, compared to its average volume of 88,323. The company has a market capitalization of $37.10 million, a price-to-earnings ratio of -0.78 and a beta of 0.49. The company's 50 day moving average is $3.08 and its two-hundred day moving average is $3.99. Clene has a one year low of $2.28 and a one year high of $8.60.
Read Our Latest Research Report on CLNN
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider OSI Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OSI Systems wasn't on the list.
While OSI Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
